Ra Capital Management, L.P. - Dec 11, 2023 Form 4/A Insider Report for Wave Life Sciences Ltd. (WVE)

Role: Director, 10%+ Owner
Signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol: WVE
Transactions as of: Dec 11, 2023
Transactions value $: $5,000,000
Form type: 4/A
Date filed: 1/17/2024, 07:06 PM
Date Of Original Report: Dec 13, 2023
Previous filing: Sep 25, 2023
Next filing: Jan 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WVE	Common Stock	Purchase	$5M	+1M	+5.81%	$5.00	18.2M	Dec 11, 2023	See Footnotes	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the Securities and Exchange Commission on December 8, 2023.
F2	Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3	RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F4	This amendment is being filed solely to rectify a clerical error in column 5 which reflected a total shares held as 19,202,009 where it should have read 18,202,009.

Remarks:

Dr. Peter Kolchinsky, a Managing Partner of the Adviser, serves on the Issuer's board of directors.